Interleukin-6 −174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: A meta-analysis (Q53320752)

13 May 2018

reason for preferred rank

meta-analysis

0 references

title

Interleukin-6 −174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: A meta-analysis (English)

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

7 December 2024

Interleukin-6 -174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21767605

7 December 2024

1 reference

single-nucleotide polymorphism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21767605

7 December 2024

author name string

Xue-Mei Han

1

1 reference

13 May 2018

Chun-Hui Wang

2

1 reference

13 May 2018

Xiutian Sima

3

1 reference

13 May 2018

Song-Yan Liu

4

1 reference

13 May 2018

language of work or name

English

0 references

publication date

13 July 2011

1 reference

13 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S030439401101010X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

https://api.elsevier.com/content/article/PII:S030439401101010X?httpAccept=text/plain

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

7 December 2024

1 reference

13 May 2018

volume

504

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

4-8

1 reference

13 May 2018

Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease

7 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population.

7 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease.

7 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Cognitive function in young and adult IL (interleukin)-6 deficient mice

7 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Forecasting the global burden of Alzheimer’s disease

7 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Transgenic models to assess the pathogenic actions of cytokines in the central nervous system

7 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe

7 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.

7 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interaction between interleukin-6 and intercellular adhesion molecule-1 genes and Alzheimer's disease risk

7 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

CD14 receptor polymorphism and Alzheimer's disease risk.

7 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project

7 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease

7 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Meta-analysis in clinical trials

7 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Bias in meta-analysis detected by a simple, graphical test

7 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk.

7 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

7 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Gene-gene interaction between CARD8 and interleukin-6 reduces Alzheimer's disease risk

7 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Physiological and pathological roles of interleukin-6 in the central nervous system

7 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Quantifying heterogeneity in a meta-analysis

7 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

7 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Gene-gene interaction between interleukin-6 and interleukin-10 reduces AD risk.

7 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease

7 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interleukin-6 gene (-174 C/G ) and apolipoprotein E gene polymorphisms and the risk of Alzheimer disease in a Polish population.

7 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

INTERLEUKIN-6 PROMOTER POLYMORPHISM AND LATE-ONSET ALZHEIMER's DISEASE IN THE FINNISH POPULATION

7 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

7 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain

7 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Statistical aspects of the analysis of data from retrospective studies of disease

7 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk

7 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Anti-inflammatory drugs and Alzheimer disease.

7 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected].

7 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.

7 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study

7 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

No association between cytokine gene polymorphism and risk of Alzheimer´s disease in Slovaks

7 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interleukin-6, a mental cytokine.

7 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients

7 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study.

7 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease.

7 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Is IL-6 both a cytokine and a neurotrophic factor?

7 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Neuropathologic changes in Alzheimer's disease

7 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease

7 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2011.06.055

7 December 2024

Identifiers

1 reference

13 May 2018

release_k6b2sua3ejcfxcbxvoqhbuxcvm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k6b2sua3ejcfxcbxvoqhbuxcvm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

13 May 2018